San Antonio, TXNCT06910657Now EnrollingIRB Ready

Colorectal Cancer Clinical Trial in San Antonio, TX

Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.

Sponsored by ViroMissile, Inc.

Quick Self-Assessment

See if you qualify for this San Antonio location

Preparing your pre-screening questions…

Expert Care in San Antonio

Access colorectal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colorectal cancer treatment provided free

Apply for This San Antonio Location

Check if you qualify for this colorectal cancer clinical trial in San Antonio, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Antonio

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Antonio site if eligible
  4. 4Begin participation

About This Colorectal Cancer Study in San Antonio

This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not responded to standard treatments. Oncolytic viruses are designed to infect and destroy cancer cells and have the potential to stimulate the immune system to fight the tumor. The purpose of this study is to determine the safety of IDOV-Immune, how well it is tolerated, and to identify the highest dose that can be safely given. Researchers will also study how the drug behaves in the body, how the immune system responds to it, and whether it shows any signs of shrinking tumors. Participants will receive a single intravenous (IV) infusion of IDOV-Immune and will be closely monitored for side effects and any changes in their cancer. This study is being conducted at multiple sites in the United States and Australia.

Sponsor: ViroMissile, Inc.

Who Can Participate

Inclusion Criteria

Age ≥ 18 years.
Histologically or cytologically confirmed advanced solid tumors that have progressed despite standard therapy, or for which no standard therapy exists.
ECOG performance status ≤ 1.
Measurable disease per RECIST v1.1.
Adequate organ and bone marrow function.
At least 28 days since major surgery, prior immunotherapy, or radiotherapy (with exceptions for minor procedures).
Negative pregnancy test for women of childbearing potential.
Agreement to use effective contraception during treatment and for 3 months after.
Ability to provide informed consent and comply with study requirements. Key

Exclusion Criteria

Prior treatment with an oncolytic virus.
Active or recent vaccinia virus infection or smallpox/monkeypox vaccination within 10 years.
Active uncontrolled infection requiring systemic treatment.
History of hepatitis B, hepatitis C, or HIV (unless meeting protocol-specific criteria).
Unresolved ≥ Grade 2 toxicities from prior therapies (except hair loss or stable chronic conditions).
Active or symptomatic autoimmune disease requiring systemic therapy.
Active or untreated CNS metastases (unless stable per protocol).
Significant cardiac disease (e.g., NYHA Class III/IV heart failure).
Interstitial lung disease or prior pneumonitis requiring steroids.
Conditions requiring chronic immunosuppressive therapy.
Severe skin disorders or history of pancreatitis.
Bleeding disorders or history of recent serious thromboembolic events.
Any medical or psychiatric condition that could interfere with study participation.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Antonio?

Yes, this clinical trial (NCT06910657) has an active research site in San Antonio, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Cancer Treatment Options in San Antonio, TX

If you're searching for colorectal cancer treatment options in San Antonio, TX, this clinical trial (NCT06910657) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal cancer clinical trials near you to find additional studies recruiting in your area.

More Colorectal Cancer Trials in San Antonio, TX

See all colorectal cancer clinical trials recruiting in San Antonio — not just this study.

Browse Colorectal Cancer Trials in San Antonio →

Browse More Trials by Condition

Colorectal Cancer TrialsAll Conditions →

Ready to Join in San Antonio?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Antonio, TX